HCPCS Code Descriptor:
Injection, teplizumab-mzwv, 5 mcg
73650-0316-01, 73650-0316-10, 73650-0316-14,
Route of Administration:
Potential NDC Listing Errors:
Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.
TZIELD is a Diabetes drug manufactured by Provention Bio and administered via the Intravenous route of administration. The C Code: C9149 is aligned to the drug TZIELD.